BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9421775)

  • 1. Is single-dose antibiotic prophylaxis sufficient for coronary artery bypass surgery? An analysis of peri- and postoperative serum cefuroxime and vancomycin levels.
    Vuorisalo S; Pokela R; Syrjälä H
    J Hosp Infect; 1997 Nov; 37(3):237-47. PubMed ID: 9421775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vancomycin and cefuroxime for infection prophylaxis in coronary artery bypass surgery.
    Vuorisalo S; Pokela R; Syrjälä H
    Infect Control Hosp Epidemiol; 1998 Apr; 19(4):234-9. PubMed ID: 9605271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrupted time series analysis of vancomycin compared to cefuroxime for surgical prophylaxis in patients undergoing cardiac surgery.
    Garey KW; Lai D; Dao-Tran TK; Gentry LO; Hwang LY; Davis BR
    Antimicrob Agents Chemother; 2008 Feb; 52(2):446-51. PubMed ID: 18025116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery.
    Bertholee D; ter Horst PG; Hijmering ML; Spanjersberg AJ; Hospes W; Wilffert B
    Int J Clin Pharm; 2013 Oct; 35(5):798-804. PubMed ID: 23794078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery.
    Sisto T; Laurikka J; Tarkka MR
    Scand J Thorac Cardiovasc Surg; 1994; 28(3-4):143-8. PubMed ID: 7792559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
    Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
    Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting.
    Nooyen SM; Overbeek BP; Brutel de la Rivière A; Storm AJ; Langemeyer JJ
    Eur J Clin Microbiol Infect Dis; 1994 Dec; 13(12):1033-7. PubMed ID: 7889965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.
    Aalbers M; ter Horst PG; Hospes W; Hijmering ML; Spanjersberg AJ
    Int J Clin Pharm; 2015 Aug; 37(4):592-8. PubMed ID: 25791346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of cefuroxime after continuous infusion in coronary bypass graft patients.
    Pass SE; Miyagawa CI; Healy DP; Ivey TD
    Ann Pharmacother; 2001 Apr; 35(4):409-13. PubMed ID: 11302401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefuroxime as antibiotic prophylaxis in coronary artery bypass grafting surgery.
    Mastoraki S; Michalopoulos A; Kriaras I; Geroulanos S
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):442-6. PubMed ID: 17669893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass.
    Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgery.
    Hafermann MJ; Kiser TH; Lyda C; Fish DN; Barber GR; Wempe MF; Cleveland JC
    J Thorac Cardiovasc Surg; 2014 Jun; 147(6):1925-30. PubMed ID: 24521953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical site infections after coronary artery bypass surgery, with special reference to antibiotic prophylaxis and risk factors.
    Vuorisalo S
    Ann Chir Gynaecol; 1998; 87(1):81-2. PubMed ID: 9598244
    [No Abstract]   [Full Text] [Related]  

  • 16. High pressure liquid chromatographic analysis of the serum concentration of cefuroxime after an intravenous bolus injection of cefuroxime in patients with a coronary artery bypass grafting.
    Koot MJ; IJdenberg FN; Stuurman RM; Poell J; Bras LJ; Langemeijer JJ; Lie-A-Huen L
    Pharm Weekbl Sci; 1992 Dec; 14(6):360-4. PubMed ID: 1475176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative antimicrobial prophylaxis in cardiovascular surgery. A prospective randomized trial comparing two day cefuroxime prophylaxis with four day cefazolin prophylaxis.
    Geroulanos S; Oxelbark S; Turina M
    J Cardiovasc Surg (Torino); 1986; 27(3):300-6. PubMed ID: 3514630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.
    Rowe-Jones DC; Peel AL; Kingston RD; Shaw JF; Teasdale C; Cole DS
    BMJ; 1990 Jan; 300(6716):18-22. PubMed ID: 2105115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime.
    Mastoraki E; Michalopoulos A; Kriaras I; Mouchtouri E; Falagas ME; Karatza D; Geroulanos S
    J Infect; 2008 Jan; 56(1):35-9. PubMed ID: 17983660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.
    Kirby A; Asín-Prieto E; Burns FA; Ewin D; Fatania K; Kailavasan M; Nisar S; Pericleous A; Trocóniz IF; Burke D
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):357-363. PubMed ID: 30519893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.